This Accenture Analyst Is No Longer Bullish Ahead Of Q4 Print

Accenture Plc (NYSE:ACN) shares have rebounded more than 52% since their June lows, versus a 2% gain in the S&P 500, with channel checks showing "no corresponding improvement in demand," according to Guggenheim Securities analyst Jonathan Lee.

The Accenture Analyst: Ahead of Accenture’s fiscal Q4r results on Thursday, October 1, Lee downgraded the stock from Buy to Neutral.

The Accenture Thesis: The company’s Q4 growth is in line with expectations, despite the US Federal Reserve headwind, Lee said, adding that industry conversations suggest “little urgency” has returned to large-deal decision-making,.

Check out other analyst stock ratings.

Lee explained that decision cycles remain extended and the Middle East sales impact, roughly $400 million, has yet to normalize. Channel checks indicate:

• A lack of recovery in discretionary spend
• Continued competitive pricing pressure on larger projects

Accenture is likely to report 3% year-on-year revenue growth in constant currency terms, implying below-1 % organic growth, the analyst said.

He added that growth is likely to be driven by:

• Health & Public Services due to easier compares, which is "a function of lapping the U.S. Federal headwind rather than any genuine improvement in demand,"  
• Communications, Media & Technology
• Partially offset by tougher compares in Financial Services and greater macro sensitivity in Products and Resources

Outlook: The focus during the October 14 Investor Day is likely to be on management’s initial outlook for fiscal 2027, Lee said. He expects management to project:

• Revenue growth of 2%-5%, inclusive of the inorganic contribution from the $9bn V&A program, implying organic growth of 0%-3%.
• Modest margin expansion, translating to 10-30 basis points (bps).

"In light of shares moving meaningfully higher since June troughs, an outlook along these lines would, in our view, limit meaningful upside in shares, particularly given what we feel to be a full valuation vs. the broader peer group," the analyst further wrote.

ACN Price Action: Shares of Accenture had declined by 3.45% to $183.72 at the time of publication on Friday.

Image: Shutterstock